Literature DB >> 32540906

Immune checkpoint inhibitors in cancer immunotherapy.

Megan E Himmel1, Samuel D Saibil1, Alexandra P Saltman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32540906      PMCID： PMC7828839          DOI： 10.1503/cmaj.191231

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

Review 1.  Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges.

Authors:  N A Nixon; N Blais; S Ernst; C Kollmannsberger; G Bebb; M Butler; M Smylie; S Verma
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

2.  Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Authors:  James Larkin; Vanna Chiarion-Sileni; Rene Gonzalez; Jean-Jacques Grob; Piotr Rutkowski; Christopher D Lao; C Lance Cowey; Dirk Schadendorf; John Wagstaff; Reinhard Dummer; Pier F Ferrucci; Michael Smylie; David Hogg; Andrew Hill; Ivan Márquez-Rodas; John Haanen; Massimo Guidoboni; Michele Maio; Patrick Schöffski; Matteo S Carlino; Céleste Lebbé; Grant McArthur; Paolo A Ascierto; Gregory A Daniels; Georgina V Long; Lars Bastholt; Jasmine I Rizzo; Agnes Balogh; Andriy Moshyk; F Stephen Hodi; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2019-09-28       Impact factor: 91.245

Review 3.  The blockade of immune checkpoints in cancer immunotherapy.

Authors:  Drew M Pardoll
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716
  3 in total
  4 in total

1.  Construction and Comprehensive Prognostic Analysis of a Novel Immune-Related lncRNA Signature and Immune Landscape in Gastric Cancer.

Authors:  Xiaolong Liang; Lang Zha; Gangfeng Yu; Xiong Guo; Chuan Qin; Anqi Cheng; Ziwei Wang
Journal:  Int J Genomics       Date:  2022-01-17       Impact factor: 2.326

2.  Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma.

Authors:  Haoxue Zhang; Yuyao Liu; Delin Hu; Shengxiu Liu
Journal:  Front Oncol       Date:  2022-03-08       Impact factor: 6.244

Review 3.  Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors.

Authors:  Ryuhjin Ahn; Josie Ursini-Siegel
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

Review 4.  Current cancer therapies and their influence on glucose control.

Authors:  Carly Yim; Kerry Mansell; Nassrein Hussein; Terra Arnason
Journal:  World J Diabetes       Date:  2021-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.